NCT06600347 Effect of DASH Diet and Progressive Muscle Relaxation on Cardiovascular Risks in Postmenopausal Women
| NCT ID | NCT06600347 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Cardiovascular Complication |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-06-10 |
| Primary Completion | 2024-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-06-10 with a primary completion date of 2024-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be conducted to investigate the effect of DASH diet and Progressive muscle relaxation on cardiovascular risks in postmenopausal women.
Eligibility Criteria
Inclusion Criteria: * The participant's ages will be ranged from 50- 60 years old. * Their body mass index will be ranged from 30-35 kg/m2. * All women are hypertensive at least one year postmenopause. * Their scores in perceived stress scale will be ranged from 14-40. Exclusion Criteria: * Women with systolic blood pressure (SBP) \>160 mmHg or diastolic blood pressure (DBP) \>100mmHg. * Women who have other known causes of hypertension, such as renal diseases. * Women who are using sedatives or tranquilizer or antidepressant drugs.
Contact & Investigator
Mohamed Awad, professor
STUDY DIRECTOR
Cairo University
Frequently Asked Questions
Who can join the NCT06600347 clinical trial?
This trial is open to female participants only, aged 50 Years or older, up to 60 Years, studying Cardiovascular Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06600347 currently recruiting?
Yes, NCT06600347 is actively recruiting participants. Contact the research team at mogyfarah@hotmail.com for enrollment information.
Where is the NCT06600347 trial being conducted?
This trial is being conducted at Suez, Egypt.
Who is sponsoring the NCT06600347 clinical trial?
NCT06600347 is sponsored by Cairo University. The principal investigator is Mohamed Awad, professor at Cairo University. The trial plans to enroll 90 participants.